https://european-biotechnology.com/wp-content/uploads/2024/04/Samanta_Cimitan_CEO.jpg534420Maren Kühr/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngMaren Kühr2023-08-15 10:58:002024-07-16 16:58:05Celonic Group with new CEO
Swiss Spexis AG has announced a US$2.5m capital commitment to fund a two-part pivotal Phase III study to get market approval for its inhaled cystic fibrosis antibiotic colistimethate sodium.
https://european-biotechnology.com/wp-content/uploads/2024/04/Pseudomonas_aeruginosa_cdc.jpg7191024Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2023-08-15 08:45:222024-07-09 14:37:48Spexis AG bags money for pivotal Phase III trial
With a US$1bn acquisition of Canadian Inversago Pharma, Novo Nordisk A/S fiights to maintain its dominant position in the booming weight loss drug market.
Lipid, nutrition and frozen bakery specialist Allianza Team puts £900,500 into pre-Series A financing of microbial palm oil producer Clean Food Group Ltd.
https://european-biotechnology.com/wp-content/uploads/2024/04/cellular_oil-4022602_1280.jpeg8521280Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2023-08-08 10:38:592024-07-09 14:41:11Alianza Team invests in microbial oil maker Clean Food Group
A Dutch-German team of researchers has found out that the amount of not degradable plastics is lower than estimated but that they persist for longer than previously assumed.
Researchers at the Karlsruhe Institute of Technology (KIT) have transformed enzymes into a new form: as foams, the biocatalysts prove to be extremely stable and active.
https://european-biotechnology.com/wp-content/uploads/2024/04/Bildschirmfoto_2023-08-09_um_04.46.58.png8221766Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2023-08-03 08:41:002024-07-09 15:11:45Enzyme foams morer active and stable
Valneva announces extension of existing loan agreement
Latest NewsFrench vaccine maker Valneva SE will double the amount of a US$100m debt financing granted by Deerfield Management Company and OrbiMed.
Celonic Group with new CEO
AppointmentsBasel- and Heidelberg-based CDMO Celonic Group has appointed Dr Samanta Cimitan as Chief Executive Officer (CEO).
Spexis AG bags money for pivotal Phase III trial
Latest NewsSwiss Spexis AG has announced a US$2.5m capital commitment to fund a two-part pivotal Phase III study to get market approval for its inhaled cystic fibrosis antibiotic colistimethate sodium.
Novo Nordisk takes over Inversago Pharma Inc.
Latest NewsWith a US$1bn acquisition of Canadian Inversago Pharma, Novo Nordisk A/S fiights to maintain its dominant position in the booming weight loss drug market.
Promising viral gene therapy for genetic kidney disease
Latest NewsBritish researchers have proven that a new gene can prevent progression of hereditary kidney damage in mice.
Alianza Team invests in microbial oil maker Clean Food Group
Latest NewsLipid, nutrition and frozen bakery specialist Allianza Team puts £900,500 into pre-Series A financing of microbial palm oil producer Clean Food Group Ltd.
More marine plastics than expected
Latest NewsA Dutch-German team of researchers has found out that the amount of not degradable plastics is lower than estimated but that they persist for longer than previously assumed.
ViroCell Biologics appoints new CFO
AppointmentsViroCell Biologics, based in London, Dublin and New York, has appointed Brian Collins as Chief Financials Officer.
Sygnature Discovery Ltd acquires leading Canadian CRO
Latest NewsBritish drug discovery specialist Sygnature Discovery Ltd has taken over Canadian NuChem Sciences Inc., one of North America’s largest discovery CROs
Enzyme foams morer active and stable
Latest NewsResearchers at the Karlsruhe Institute of Technology (KIT) have transformed enzymes into a new form: as foams, the biocatalysts prove to be extremely stable and active.